AcuCort’s patent is granted with 1,349 days extended patent protection in the US
AcuCort AB (AktieTorget: ACUC) today announces that the US Patent and Trademark Office (USPTO) has granted the company’s patent application for the medical formulations containing glucocorticoids for self-treatment in acute situations, “Acute Glucocorticoid Therapy”. In addition, the authority extends the duration of the patent by 1,349 days.The US patent no. 9,925,139, B2 describes medical self-treatment with glucocorticoids in emergency situations without access to medical personnel. The patent protected invention describes and covers glucocorticoids in general, which means that the